title: Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series.
abstract: Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of Parkinson's disease (PD), and therefore, most PD patients receive antidepressant drugs. Agomelatine is a recently introduced antidepressant drug acting as an MT1/MT2 melatonergic receptor agonist and 5HT2C/5HT2B serotonergic antagonist. The aim of this case series was to evaluate the role of agomelatine in the treatment of MDD associated with PD.
authors.forename: Domenico
authors.initials: D
authors.lastname: De Berardis
authors.forename: Michele
authors.initials: M
authors.lastname: Fornaro
authors.forename: Nicola
authors.initials: N
authors.lastname: Serroni
authors.forename: Luigi
authors.initials: L
authors.lastname: Olivieri
authors.forename: Stefano
authors.initials: S
authors.lastname: Marini
authors.forename: Francesco Saverio
authors.initials: FS
authors.lastname: Moschetta
authors.forename: Venkataramanujam
authors.initials: V
authors.lastname: Srinivasan
authors.forename: Maurizio
authors.initials: M
authors.lastname: Assetta
authors.forename: Alessandro
authors.initials: A
authors.lastname: Valchera
authors.forename: Anatolia
authors.initials: A
authors.lastname: Salone
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinotti
authors.forename: Marco
authors.initials: M
authors.lastname: Onofrj
authors.forename: Massimo
authors.initials: M
authors.lastname: Di Giannantonio
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D000928:Antidepressive Agents; C084711:agomelatine; D009281:Naphthalenes